Insider Transactions in Q4 2022 at Johnson & Johnson (JNJ)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2022
|
Joseph J Wolk Exec VP, CFO |
SELL
Open market or private sale
|
Direct |
14,781
-15.09%
|
$2,645,799
$179.54 P/Share
|
|
Dec 13
2022
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,781
+12.25%
|
$1,197,261
$81.49 P/Share
|
|
Nov 30
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Open market or private sale
|
Direct |
73,323
-32.23%
|
$12,831,525
$175.78 P/Share
|
|
Nov 30
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
73,323
+38.91%
|
$5,279,256
$72.54 P/Share
|
|
Nov 22
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Open market or private sale
|
Direct |
76,923
-37.82%
|
$13,538,448
$176.78 P/Share
|
|
Nov 22
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
76,923
+27.44%
|
$5,538,456
$72.54 P/Share
|
|
Nov 18
2022
|
Robert J Decker VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
16,928
-52.25%
|
$2,962,400
$175.0 P/Share
|
|
Nov 18
2022
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
16,928
+34.32%
|
$1,523,520
$90.44 P/Share
|
|
Nov 09
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Open market or private sale
|
Direct |
16,410
-18.71%
|
$2,838,930
$173.42 P/Share
|
|
Nov 09
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,410
+15.76%
|
$1,181,520
$72.54 P/Share
|
|
Nov 07
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
17,043
+13.79%
|
$1,840,644
$108.77 P/Share
|
|
Nov 04
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Open market or private sale
|
Direct |
35,246
-26.9%
|
$6,027,066
$171.18 P/Share
|
|
Nov 04
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
35,246
+21.1%
|
$4,581,980
$130.72 P/Share
|
|
Nov 02
2022
|
James D. Swanson EVP, CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,932
-35.76%
|
$676,304
$172.29 P/Share
|
|
Nov 02
2022
|
James D. Swanson EVP, CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,912
+47.41%
|
-
|
|
Oct 24
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
78,458
-0.3%
|
$13,416,318
$171.17 P/Share
|
|
Oct 24
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
78,458
+28.89%
|
$9,022,670
$115.67 P/Share
|
|
Oct 24
2022
|
William Hait EVP, Chief EI and Med Officer |
SELL
Open market or private sale
|
Direct |
15,000
-7.97%
|
$2,565,000
$171.55 P/Share
|
|
Oct 24
2022
|
William Hait EVP, Chief EI and Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+13.61%
|
$1,350,000
$90.44 P/Share
|
|
Oct 19
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
70,126
-0.46%
|
$11,500,664
$164.5 P/Share
|
|
Oct 19
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,126
+27.51%
|
$7,082,726
$101.87 P/Share
|